PAP-α Inhibitors

The inhibitors listed above primarily target processes upstream of polyadenylation, such as transcription and RNA processing, which could indirectly influence PAP-α activity. Given PAP-α's critical role in RNA maturation, modulation of these upstream processes is relevant for understanding its function and potential regulation. Cordycepin and Actinomycin D can directly affect RNA synthesis and processing, potentially impacting the substrates available for PAP-α. α-Amanitin, DRB, and compounds inhibiting RNA polymerase II or III would decrease the synthesis of RNA substrates for PAP-α.

Flavopiridol and Triptolide, by inhibiting factors involved in transcriptional elongation and initiation, might indirectly affect PAP-α activity. Leptomycin B and Selinexor, affecting nuclear export, could indirectly influence the dynamics of RNA substrates processed by PAP-α. CX-5461, by inhibiting RNA Polymerase I, might influence ribosomal RNA synthesis, thereby indirectly affecting PAP-α's role in mRNA processing. Spliceosome inhibitors like Meayamycin B and Pladienolide B could impact the maturation of pre-mRNA substrates for PAP-α.